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Abstract The precise relation between heart rate vari-
ability (HRV) and autonomic re-innervation has not been
established explicitly in patients after orthotopic heart
transplantation (OHT), but can be inferred from the fact that
the HRV is reduced immediately after OHT and may
increase gradually with time. The aim of this study was to
investigate the residual HRV in patients about 1–2 years
after OHT, as compared with patients after coronary artery
bypass graft (CABG) surgery. Thirteen patients who had
received OHT and 14 patients who had received CABG
surgery were recruited. HRV analysis was performed and
the HRV measures in supine position were compared
between these two groups of patients. We found that the
mean (mRRI), standard deviation and coefficient of varia-
tion of RR intervals, total power, very low frequency power
(VLFP), low frequency power, high frequency power (HFP),
normalized VLFP (nVLFP) and low-/high-frequency power
ratio in the OHT group were all significantly decreased,
while the heart rate (HR) and normalized HFP (nHFP) were
significantly increased, as compared with the CABG group.
The decrease in HRV was more severe in the VLFP region.
A smaller nVLFP and a greater nHFP were associated with a
smaller mRRI and a larger HR in the OHT patients. The
slope of the power law relation of HRV became positive in
OHT patients, instead of negative in CABG patients. We
conclude that patients after OHT have residual HRV which
were characterized by severely depressed time and fre-
quency domain HRV, increased HR and nHFP, decreased
nVLFP, and positive slope of the power-law relation of
HRV. The use of nHFP as the indicator of vagal modulation
and the use of nVLFP as the indicator of renin-angiotensin
modulation, thermoregulation and vagal withdrawal must be
careful in the OHT patients.
Keywords Autonomic nervous system  Heart
transplantation  Heart rate variability  Re-innervation
1 Introduction
Spontaneous beat-to-beat fluctuation in heart rate (HR)
reflects the ongoing modulation of sinus node activity through
several cardiovascular control mechanisms [1]. This fluctua-
tion in heart rate is termed heart rate variability (HRV), and
can be quantified by the mathematical technique of power
spectral analysis, which calculates the frequency contents of
the time-varying signals and plots the power of the frequency
bands as a function of frequency. The spectrum obtained from
power spectral analysis of sequences of RR intervals (RRI)
can be divided mainly into two parts, a low frequency (LF)
component and a high frequency (HF) component. The LF
component is thought to be related to both sympathetic and
vagal innervations, while the HF component is thought to be
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related to the vagal innervation alone on the basis of exper-
iments involving specific intravenous autonomic blocking
agents [2–4]. Below the LF range, a very-low frequency
range and an ultra-low frequency range have been suggested.
The very-low frequency range reflects the renin-angiotensin-
aldosterone modulation and vagal withdrawal [5–7], and the
ultra-low frequency range is often used in the power law
relationship [8]. The HRV measures can be used as non-
invasive prognostic indices of the autonomic nervous modu-
lation of the subjects with many kinds of diseases [9–12]. For
instance, reduced cardiac vagal modulation has been reported
in patients with coronary artery disease (CAD) [13, 14], and
the reduction in the cardiac vagal modulation was found to
correlate with the angiographic severity, independent of pre-
vious myocardial infarction, location of diseased coronary
arteries, and left ventricular function [15].
Although the re-innervation might be inferred from the
HRV analysis, the real time course of change in HRV after
orthotopic heart transplantation (OHT) has not been fully
established yet. Partial re-innervation of both sympathetic
and vagal branches has been reported after OHT in dogs
[16–18]. The cardiac denervation associated with OHT and
subsequent potential for re-innervation have been the focus
of interest among clinicians, physiologists, and pharmacol-
ogists [19]. In a study using 24-h Holter recordings per-
formed on 37 ambulant patients 1–122 months after cardiac
transplantation, patients [36 months after transplant had
lower 24-h HR, an increased average of all 5-min SDs of
NN intervals, and higher low-frequency power (LFP) and
high-frequency power (HFP), suggesting that patients late
after cardiac transplantation have HRV evidence for an
increase in sympathetic control of the heart [20]. In another
10-year longitudinal follow-up study, the observed increase
in total power (TP), absolute LFP and HFP, but unchanged
relative LFP and HFP after heart transplantation are com-
patible with partial re-innervation of the cardiac sinus node
[21]. Thus, whether re-innervation has occurred and to what
extent has re-innervation occurred is a matter of uncertainty.
We hypothesized that unless the re-innervation is nearly
complete, the HRV measures may not be regarded as the
true indices of autonomic nervous modulation of the OHT
patients. Thus, the aim of this study was to examine the
residual HRV in patients 1–2 years after OHT to see if




This was a prospective case–control study. The Institu-
tional Review Board (responsible person: Dr. Fa-Yauh
Lee) of Taipei Veterans General Hospital, a tertiary med-
ical center in Taiwan, has approved this study, and a
written informed consent was obtained from each subject
before the study. Patients who had received OHT because
of dilated cardiomyopathy or ischemic cardiomyopathy
about 1–2 years before the HRV study were recruited as
the study group. At the time of HRV study, the post-
transplantation follow-up period in the OHT group was
16.5 (median) (IQR 15.3–17.0) months, ranging from 13 to
24 months. If clinical condition allowed, no autonomic
blocking agent was used on the patients for at least 24 h
prior to the study. For ethical reason, patients who had
signs or symptoms of active cardiorespiratory distress were
excluded from this study. Electrocardiographic (ECG)
signals and relevant clinical and laboratory data were
collected during the scheduled routine follow-up visits.
Patients about 1–2 years after coronary artery bypass
graft (CABG) surgery were recruited as the control group.
Cardiopulmonary bypass was accomplished with single
venous and single arterial cannulation at the ascending
aorta. The exclusion criteria included atrial fibrillation,
myocardial infarction within 6 months, or using class I
antiarrhythmic medication. The CABG patients were
recruited as the control group because they had received
open chest surgery as the OHT patients did, but did not
have their cardiac autonomic nervous innervation injured
as the OHT patients did. In addition, some OHT patients
had underlying ischemic heart disease before surgery,
similar to the CABG patients. Thus, the CABG patients
were chosen as the control group in this study.
2.2 HRV analysis
All subjects were instructed not to drink caffeinated bev-
erages for at least 24 h prior to ECG recording. After 5 min
rest in supine position, a trend of ECG signals was picked
up by a bedside ECG monitor (Biochem Vital Sign Mon-
itor, BCI International, Waukesha, Wisconsin, USA), and
was transmitted to a personal computer for recording for
15 min. During the rest and recording periods, the patient
was asked to close his/her eyes to avoid visual interference
from the environment. The sampling frequency for ECG
recording was 500 Hz.
The recorded ECG signals were retrieved afterwards to
measure the consecutive RRI by using the software for the
detection of R waves. Sinus pauses and atrial or ventricular
arrhythmia were deleted, and the last 512 stationary RRI
were obtained for HRV analysis. If the percentage of
deletion was [5 %, then the patient was excluded from
statistical analysis.
The mean (mRRI), standard deviation (SDRR) and
coefficient of variation (CVRR) of 512 stationary RRI were
calculated using standard formulae for each subject. The
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power spectra of RRI were obtained by means of fast Fourier
transformation (Mathcad 11, Mathsoft Inc., Cambridge, MA,
USA). Direct current component was excluded before the
calculation of the power. The area-under-the-curve of the
spectral peaks within the range of 0.01–0.4, 0.01–0.04,
0.04–0.15, 0.15–0.40 Hz were defined as the TP, very low-
frequency power (VLFP), LFP, and HFP, respectively. The
normalized VLFP (nVLFP = VLFP/TP), normalized LFP
(nLFP = LFP/TP), normalized HFP (nHFP = HFP/TP), and
low-/high-frequency power ratio or low-/high- ratio in short
(LHR = LFP/HFP) were used as the indices of renin-an-
giotensin modulation, thermoregulation and vagal with-
drawal, combined sympathetic and vagal modulation, vagal
modulation, and sympatho-vagal balance, respectively [22].
The HRV is known to be affected by a complex inter-
play of neural, humoral, and electrophysiological factors,
which in turn are modulated by central and peripheral
oscillators [23]. In order to evaluate the complexity of the
controlling system of HR in patients after OHT, the power-
law characteristics of HRV was obtained by plotting the
logarithm of power against the logarithm of frequency to
obtain a regression line that can be described by three
parameters, i.e., the Pearson correlation coefficient q,
slope, and Y-intercept [24–29]. Briefly, the linear regres-
sion analysis between log(power) and log(frequency)
within the frequency range of 0.01 and 0.5 Hz was per-
formed by least-square method to obtain the three param-
eters of best fit regression line.
2.3 Statistical analysis
Mann–Whitney rank sum test (SigmaStat statistical soft-
ware, SPSS Inc., Chicago, Illinois, USA) was employed to
compare the baseline characteristics and the HRV measures
between OHT and CABG groups. Chi-square or Fisher exact
test when appropriate was employed to compare the cate-
gorical data of the baseline characteristics between OHT and
CABG groups. The correlation between the time interval
between OHT surgery and HRV analysis, and between HRV
measures and power-frequency relation characteristics in
patients after CABG or OHT surgery were assessed by
Pearson product moment correlation analysis. The data are
presented as medians and interquartile range (25–75 %). A
P\ 0.05 was considered statistically significant.
3 Results
3.1 Clinical and hemodynamic characteristics
Thirteen patients after OHT surgery were included in the
OHT group. At the time of surgery, the recipients’ age was
55.0 (43.5–66.0) years, ranging from 34 to 75 years. All
patients in the OHT group were receiving immunosup-
pressive therapy. Endomyocardial biopsy did not show
evidence of tissue rejection in all OHT patients at the time
of study. Nine OHT patients were classified as NYHA class
2, and four patients were classified as NYHA class 3. Five
patients in the OHT group were transplanted due to dilated
cardiomyopathy, seven patients due to ischemic car-
diomyopathy, and one patient due to rheumatic heart dis-
ease with severe mitral stenosis and regurgitation.
Fourteen patients 1–2 year after CABG surgery were
recruited as the control group. A mean of 4.1 grafts per
patient was anastomosed using saphenous vein and internal
mammary artery. All patients improved symptomatically
after CABG surgery during the follow-up period. There
were no neurological symptoms or signs after CABG in
these patients. The CABG patients were classified as
NYHA class 1–2 when HRV analysis was performed.
Table 1 shows the basic and hemodynamic data of the
patients in the OHT and CABG groups. Diabetes mellitus was
defined as fasting blood glucose 126 mg/dl or higher. Hyper-
tension was defined as systolic blood pressure[140 mmHg or
diastolic blood pressure [90 mmHg. Hyperlipidemia was
defined as total cholesterol [200 mg/dl or low density
lipoprotein cholesterol[100 mg/dl. All patients in the CABG
group had coronary artery disease (CAD) with 2 or 3 vessels
diseases, and 12 out of 13 patients in the OHT group had
cardiomyopathy. That’s the reason why they received CABG
or OHT surgery, respectively. Most patients in the CABG
group were using nitrates, while most patients in the OHT
group were using immunosuppressants and prednisolone.
3.2 HRV after OHT and CABG
Figure 1 show the representative power spectra and power
law relation of HRV in supine positions in a patient in the
CABG group and a patient in the OHT group, respectively.
While the nVLFP and LHR of the OHT patient were lower
than those of the CABG patient, the nHFP of the OHT
patient was higher than that of the CABG patient. Simi-
larly, while the slope of the power-law characteristics of
HRV was negative in the CABG group, it became positive
in the OHT group.
The left panels of Fig. 2 compares the time-domain
HRV measures between the CABG group and the OHT
group. While the HR was significantly greater, the mRRI,
SDRR and CVRR of the OHT patients were all significantly
smaller than those of CABG patients. The middle and right
panels of Fig. 2 compare the frequency-domain HRV
measures between CABG and OHT groups. The TP, VLFP,
LFP, HFP, nVLFP, and LHR of the OHT patients were all
significantly smaller than those of the CABG patients. In
contrast, the nHFP of the OHT patients was significantly
greater than that of the CABG patients.
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Figure 3 shows the comparison of the characteristics of
the power-frequency relationship between two groups of
patients. Though there were no significant differences in
the correlation coefficient and the Y-intercept between the
CABG and OHT groups, the slope was significantly dif-
ferent between these two groups of patients. It is note-
worthy that while the slope was negative in the CABG
group, it became positive in the OHT group.
3.3 Correlation analysis
Figure 4 shows that the mRRI correlated significantly and
negatively with nLFP in the CABG patients, but not in the
OHT patients. In contrast, the mRRI correlated
significantly and positively with nVLFP and significantly
and negatively with nHFP in the OHT patients, but not in
the CABG patients. Thus, a smaller nVLFP and a greater
nHFP were associated with a smaller mRRI in the OHT
patients.
Figure 5 shows that the LVEF correlated significantly
and negatively with SDRR, CVRR, and LFP in the OHT
group. A larger SDRR, CVRR, and LFP were associated
with a smaller LVEF. In other words, an increase in global
HRV or combined sympathetic and vagal modulation was
associated with a decrease in LV function, if the LFP could
still be regarded as an index of combined vagal and sym-
pathetic modulation of the patients 1–2 years after OHT
surgery.
Table 1 Baseline
characteristics of patients in the
CABG and OHT groups
CABG group (n = 14) OHT group (n = 13) P value
Age (years) 63.5 (55.5-66.3) 56.0 (44.5-67.0) 0.319
Gender (M/F) 12/2 12/1 1.000
Body height (cm) 162 (157–168) 165 (162–170) 0.230
Body weight (kg) 64 (57–80) 64 (59–72) 0.923
BMI (kg/m2) 25.1 (22.1–27.0) 22.9 (21.6-27.3) 0.790
Post-OHT period (month) – 16.5 (15.3-17.0)
History
Previous MI 5 1 0.198
Cardiomyopathy 0 12 \0.001
CAD 14 3 \0.001
Hypertension 11 10 0.719
Diabetes mellitus 6 8 0.558
Hyperlipidemia 4 5 0.892
Medication
Beta-blocker 5 1 0.198
Calcium antagonist 9 13 0.059
Nitrates 12 0 \0.001
ACE inhibitor 6 4 0.802
Digitalis 2 0 0.496
Aspirin 10 9 0.767
Immunosuppressants 0 13 \0.001
Prednisolone 0 13 \0.001
Clinical status
LVEDP (mmHg) 14.5 (13.0–17.0) –
LVEF (%) 48.5 (45.0–53.0) –
NYHA functional class 2.0 (2.0–3.0) –
Two-vessel disease 2 2 0.644
Three-vessel disease 12 1 \0.001
Left main disease 4 1 0.368
LV aneurysm 3 0 0.247
Values are presented as medians (25–75 %)
OHT orthotopic heart transplantation, BMI body mass index, ACE angiotensin-converting enzyme, LV left
ventricle, LVEDP left ventricular end-diastolic pressure, LVEF left ventricular ejection fraction, MI
myocardial infarction, CAD coronary artery disease, NYHA New York Heart Association
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Table 2 shows that the slope of linear regression anal-
ysis between log(power) and log(frequency) within the
frequency range of 0.01 and 0.5 Hz correlated significantly
and positively with nHFP, and correlated significantly and
negatively with nVLFP and LHR in both CABG and OHT
groups. An additional significant and negative correlation
was found between the slope and nLFP in the OHT group,
but not in the CABG group.
There were no significant correlations between the time
interval after OHT surgery and the HRV measures in the
OHT group (data not shown).
4 Discussion
By using HRV analysis, we found that the patients after
OHT had smaller time and frequency domain HRV mea-
sures than those of the patients after CABG, except that the
HR and nHFP of the OHT patients were greater than those
of CABG patients. The depression in various frequency
domain HRV measures was more severe in the VLF range.
A greater nVLFP is associated with a larger mRRI in the
OHT patients. In contrast to the CABG patients and other
kinds of patients, the slope of the power-law relation of
HRV between log(power) and log(frequency) became
positive in the patients after OHT.
In this study, the increase in both HR and nHFP and a
simultaneous decrease in LHR suggested that the use of
nHFP as the index of vagal modulation and the use of LHR
as the index of sympathetic modulation might be doubtful in
patients 1–2 years after OHT, because a higher HR is sup-
posed to be associated with a lower, rather than higher, vagal
modulation. Correlation analysis showed that a larger nHFP
and a smaller nVFLP were associated with a decrease in
mRRI in OHT patients. This is very strange if nHFP is
regarded as the indicator of vagal modulation and nVLFP as
the indicator of renin-angiotensin modulation, thermoregu-
lation and vagal withdrawal. An increased vagal modulation
and decreased vagal withdrawal are expected to lead to a
prolonged mRRI, rather than decreased mRRI. This peculiar
relation between mRRI and nHFP or nVLFP also suggested
that the interpretation of nHFP as the index of vagal
Fig. 1 Representative power spectra of HRV in supine position in a patient in the CABG group and a patient in the OHT group. nu normalized
unit, PSD power spectral density
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modulation and nVLFP as the index of renin-angiotensin
modulation, thermoregulation and vagal withdrawal must be
careful in OHT patients 1–2 years after surgery. Other kinds
of unknown mechanism might have contributed to the
increase in nHFP and the decrease in nVLFP in OHT
patients, as compared with the CABG patients.
Lai et al. [30] indicated that OHT recipients’ HRV was
significantly lower than that of healthy adults in terms of
Fig. 2 Comparison of HRV measures between CABG and OHT
groups. *P\ 0.05 versus CABG (Mann–Whitney rank sum test).
While the HR was significantly greater, the mRRI, SDRR and CVRR of
the OHT patients were all significantly smaller than those of the
CABG patients. The TP, VLFP, LFP, HFP, nVLFP, LHR of the OHT
patients were all smaller than those of the CABG patients, while the
nHFP of the OHT patients was higher than that of the CABG patients
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mean, SDRR, total power, low frequency, low frequency
(nu), high frequency and low frequency/high frequency. In
this study we found similarly that the HRV of OHT
patients was severely decreased, as compared to that of
CABG patients. Although the HFP of the OHT patients
was significantly smaller than that of CABG patients, the
nHFP in the OHT patients was greater than that of CABG
patients in this study. The seemingly strange finding of
increased nHFP in patients after OHT might be caused by
the severely depressed VLF band relative to other fre-
quency bands in the power spectrum. The finding of sup-
pressed VLF band in patients after OHT seemed to be in
accordance with the findings of Hadase et al. [31] have
shown that the VLFP is a marker of poor recovery of
autonomic control of HR in patients with congestive heart
failure because a small VLFP is associated with a
decreased event-free rate.
The mechanisms responsible for the loss of HRV
1–2 years after OHT might be multiple. First, the proce-
dure of denervation after OHT should have sacrificed the
intricate network of neural inter-organ connections and
feedback mechanisms, producing a state of loss of
complexity in the HR control system. Second, the medi-
cation used by the patients following OHT might affect the
HRV of the patients. For instance, Schneider et al. [32]
have shown that fetuses exposed to betamethasone in utero
have an acute shift in the sympatho-vagal balance toward
sympathetic suppression. Therapondos et al. [33] have
reported that the HRV would be worsened by the aza-
thioprine and prednisolone used in immunosuppression in
cirrhosis patients who had received orthotopic liver
transplantation.
The origin of power law characteristics has been spec-
ulated to be a manifestation of complex interaction
between the heart and the autonomic nervous system.
Bigger et al. [8] have shown that the power law regression
parameters are excellent predictors of death of any cause or
arrhythmic death and predict these outcomes better than
traditional power spectral bands, and that myocardial
infarction or denervation of the heart causes a steeper slope
and decreased height of the power law regression relation
between log(power) and log(frequency) of RR-interval
fluctuations. Huikuri et al. [34] have shown that the power-
law relationship of 24-h HR variability is a more powerful
predictor of death than the traditional risk markers in
elderly subjects, and that altered long-term behavior of HR
implies an increased risk of vascular causes of death rather
than being a marker of any disease or frailty leading to
death. The presence of a positive slope in OHT patients
instead of a negative one in many kinds of diseases [24–29]
seems to echo the assertion of those studies that power law
regression parameters are excellent predictors of diseases
than the traditional power spectral bands parameters. From
Fig. 2, it is speculated that the positive value for the slope
of the power law relation of HRV might be caused by the
suppression of the power in the VLF range (0.04–0.01 Hz)
and the relative enhancement of the powers in the HF range
in OHT patients.
Discontinuation of autonomic blocking agents such as
beta-blockers for at least 24 h prior to ECG recording was
requested if clinical condition allowed. However, if the
medication was still needed, the discontinuation of the
medications before and during the study was not consid-
ered because it was not ethical to risk the patients of pos-
sible episodes of heart attack or heart decompensation.
Thus, some patients in both OHT and CABG groups were
still using beta-blockers that may have effect on the HRV.
Though beta-blockers can affect HRV, the use of beta-
blockers between these two groups of patients was not
statistically significant. Therefore, the influence of this
confounding factor can be neglected in this study.
All OHT patients in this study were given immuno-
suppresants and prednisolone to suppress possible rejection
reaction. It is therefore interesting to know whether there is
a relationship between immunosuppression and
Fig. 3 Comparison of power law characteristics of HRV between
CABG and OHT groups. *P\ 0.05 versus CABG (Mann–Whitney
rank sum test)
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Fig. 4 Linear correlations between mRRI and normalized HRV
measures in the CABG and OHT patients. The mRRI correlates
significantly and negatively with nLFP in CABG patients, but not
OHT patients. On the other hand, the mRRI correlates significantly
and positively with nVLFP and significantly and negatively with
nHFP in OHT patients, but not CABG patients. mean RRI mean RR
interval, nVLFP normalized very low-frequency power, nLFP
normalized low-frequency power, nHFP normalized high-frequency
power, LHR low-/high- frequency power ratio
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sympathetic control through variations in the inflammatory
state of the patient. In this study, it is impossible to com-
pare the difference in the indices of sympathetic control
between those OHT patients who have been given
immunosuppresants and those patients who haven’t.
However, from the literature, we know that cyclosporine-
induced hypertension is associated with sympathetic neu-
ral activation, which may be accentuated by the cardiac
denervation that results from heart transplantation [35]. In
contrast, Schneider et al. [32] showed that there was an
acute shift in the sympatho-vagal balance in fetuses
exposed to betamethasone in utero toward sympathetic
suppression. The immunosuppresants and steroid given to
the OHT patients seem to have opposite effects on their
HRV and hemodynamics. There might be a complex
relation among the immunosuppression, steroid therapy
and sympathetic control in the OHT patients. The final
result of immunosuppressants and steroid on the sympa-
thetic modulation of OHT patients remains to be
determined.
Halpert et al. [20] have showed in a 10-year longitudinal
follow-up study that the observed increase in TP, absolute
LFP and HFP, but unchanged relative LFP and HFP after
heart transplantation are compatible with partial re-inner-
vation of the cardiac sinus node. Cornelissen et al. [21]
have showed that the changes in HRV during long-term
follow-up after heart transplantation are compatible with
the cardiac sinus node, as has been suggested by cross-
sectional studies. However, Beckers et al. [36] have
showed in another 10-year follow-up study indicated that
the vast majority of the heart transplantation showed no
signs of reinnervation. Lovric et al. [37] also pointed that
eventual sinus node sympathetic reinnervation and left
ventricular sympathetic reinnervation do not occur simul-
taneously. Although the HRV measures may not be able to
represent the autonomic modulation of the OHT patients
when the re-innervation of the sinus node has not reached
an appreciable degree after the surgery, the studies of
Halpert et al. [20], Cornelissen et al. [21], and Beckers
et al. [36] suggested that some HRV measures such as TP,
LFP, and HFP may be associated with the re-innervation of
the sinus node in the OHT patients. If this is true, then
some HRV measures may be included in the post-trans-
plantation rehabilitation criteria so that the progression of
cardiac re-innervation and the restoration of autonomic
control of the heart can be monitored serially and non-
invasively.
In conclusion, patients after OHT have residual HRV
which were characterized by severely depressed time and
frequency domain HRV, increased HR and nHFP,
decreased nVLFP, and a positive value for the slope of
the power-law relation of HRV. There was a severe
depression in the VLF band among various frequency
bands in the power spectrum of RRI in patients after
OHT. The interaction between the transplanted heart and
various controlling systems might account for the resid-
ual HRV in patients after OHT. The use of nHFP as the
indicators of vagal modulation and the use of nVLFP as
the indicator of renin-angiotensin modulation, ther-
moregulation and vagal withdrawal must be careful in
the OHT patients.
Fig. 5 Significant correlations between left ventricular ejection
fraction (LVEF) and HRV measures in the OHT group. The LVEF
correlates significantly and negatively with SDRR, CVRR, and LFP in
the OHT patients. SDRR standard deviation of RR intervals, CVRR
coefficient of variation of RR intervals, LFP low-frequency power
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